<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Methoxphenidine - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚ÜÅE<a href="/dyos-domain/dissociatives/">Dissociatives</a> ‚ÜÅE<span>Methoxphenidine</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üåÄ Methoxphenidine</h1>
        <h2 class="chemical-name">1-[1-(2-Methoxyphenyl)-2-phenylethyl]pyrrolidine</h2>
          <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Methoxphenidine" 
                data-category="Dissociatives" 
                data-chemical="1-[1-(2-Methoxyphenyl)-2-phenylethyl]pyrrolidine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Common Names</h4>
              <span>MXP</span> ‚Ä¢ <span>Methoxphenidine</span> ‚Ä¢ <span>2-MXP</span>
            </div>
            <div class="name-category">
              <h4>Research Chemical Names</h4>
              <span>MXP HCl</span> ‚Ä¢ <span>2-Methoxphenidine</span> ‚Ä¢ <span>Methoxphenidine Hydrochloride</span>
            </div>
            <div class="name-category">
              <h4>Chemical Structure Names</h4>
              <span>Diarylethylamine</span> ‚Ä¢ <span>2-MeO-Diphenidine analog</span> ‚Ä¢ <span>Pyrrolidine derivative</span>
            </div>
            <div class="name-category">
              <h4>Chemical Abbreviations</h4>
              <span>MXP-HCl</span> ‚Ä¢ <span>2-MeO-1,2-DEP</span> ‚Ä¢ <span>N-Pyrrolidyl-2-MeO-diphenylethylamine</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category research">Research Chemical</span>
          <span class="legal-status mixed">Variable Legal Status</span>
          <span class="duration very-long">6-12 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/Dyo-s-Dubious-Domain/assets/substances/methoxphenidine.jpg" alt="MXP powder and molecular structure diagram" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅ‚ÇâH‚ÇÇ‚ÇÉNO</p>
            <p>MW: 281.39 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure Methoxphenidine (HCl salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine powder, occasionally clumpy</li>
            <li><strong>Odor:</strong> Generally odorless or faint chemical smell</li>
            <li><strong>Taste:</strong> Bitter, numbing, unpleasant</li>
            <li><strong>Solubility:</strong> Moderately soluble in water, soluble in alcohol</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Research Chemical Forms</h4>
          <ul>
            <li><strong>Powder:</strong> Most common form, typically white powder</li>
            <li><strong>Capsules:</strong> Pre-measured doses in gelatin capsules</li>
            <li><strong>Crystals:</strong> Less common, larger crystalline formations</li>
            <li><strong>Pressed tablets:</strong> Rare, usually mixed with other substances</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†ÔøΩEÔøΩEContamination & Substitution Risks</h4>
          <p><strong>Structural analogs:</strong> Often confused with diphenidine, 2-MeO-diphenidine</p>
          <p><strong>Substitutes:</strong> Other dissociatives may be sold as MXP</p>
          <p><strong>Purity issues:</strong> Variable synthesis quality, unknown impurities</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Information</h3>
      <div class="dosage-warning">
        <p><strong>‚ö†ÔøΩEÔøΩEEXTREME CAUTION:</strong> Methoxphenidine has highly unpredictable effects with significant individual variation. The dose-response relationship is poorly understood, and effects can vary dramatically between sessions.</p>
      </div>
      
      <div class="dosage-routes">
        <h4>Oral Administration</h4>
        <div class="dosage-chart">
          <div class="dose-range threshold">
            <span class="range-label">Threshold</span>
            <span class="dose-amount">25-50mg</span>
            <div class="dose-bar"></div>
          </div>
          <div class="dose-range light">
            <span class="range-label">Light</span>
            <span class="dose-amount">50-75mg</span>
            <div class="dose-bar"></div>
          </div>
          <div class="dose-range common">
            <span class="range-label">Common</span>
            <span class="dose-amount">75-125mg</span>
            <div class="dose-bar"></div>
          </div>
          <div class="dose-range strong">
            <span class="range-label">Strong</span>
            <span class="dose-amount">125-200mg</span>
            <div class="dose-bar"></div>
          </div>
          <div class="dose-range heavy">
            <span class="range-label">Heavy/Hole Risk</span>
            <span class="dose-amount">200mg+</span>
            <div class="dose-bar dangerous"></div>
          </div>
        </div>
        
        <h4>Insufflated (Nasal) - NOT RECOMMENDED</h4>
        <div class="insufflation-warning">
          <p><strong>‚ö†ÔøΩEÔøΩEAVOID:</strong> Nasal administration is highly caustic and causes severe nasal damage. Stick to oral administration only.</p>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosage Considerations</h4>
        <ul>
          <li><strong>Unpredictable potency:</strong> Same dose can produce vastly different effects</li>
          <li><strong>Extremely long duration:</strong> 6-12+ hours makes redosing dangerous</li>
          <li><strong>Slow onset:</strong> Can take 2-4 hours to reach peak effects</li>
          <li><strong>Individual variation:</strong> Some users extremely sensitive</li>
          <li><strong>No established dosing:</strong> Limited human data available</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Fatal Warning:</strong> The extremely long duration combined with unpredictable potency makes MXP particularly dangerous. Users have reported being incapacitated for 12+ hours from single doses.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Oral)</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Onset - subtle dissociation, stimulation</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-6:00</span>
          <span class="effect">Peak - strong dissociation, potential holes</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+6:00-12:00</span>
          <span class="effect">Plateau - continued effects, gradual decline</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+12:00-24:00</span>
          <span class="effect">Afterglow - lingering dissociation, fatigue</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÅEReported Positive Effects</h4>
          <ul>
            <li>Dissociative experiences and ego dissolution</li>
            <li>Mild euphoria and mood elevation</li>
            <li>Enhanced introspection</li>
            <li>Stimulating properties (unlike most dissociatives)</li>
            <li>Unique "warm" dissociation</li>
            <li>Pain relief and analgesia</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùÅEDangerous Side Effects</h4>
          <ul>
            <li>Extreme duration (12+ hours)</li>
            <li>Unpredictable onset and intensity</li>
            <li>Complete motor impairment in holes</li>
            <li>Confusion and disorientation</li>
            <li>Nausea and vomiting</li>
            <li>Memory blackouts</li>
            <li>Potential for manic episodes</li>
          </ul>
        </div>
      </div>
      
      <div class="unique-properties">
        <h4>üß™ Unique Properties</h4>
        <p><strong>Diarylethylamine structure:</strong> Unlike ketamine/PCP analogs, MXP has a fundamentally different chemical backbone, leading to unique and unpredictable effects.</p>
        <p><strong>Stimulating dissociation:</strong> Users report it's more stimulating than other dissociatives, potentially causing agitation or mania.</p>
        <p><strong>Variable pharmacology:</strong> Effects seem to vary dramatically between individuals and sessions.</p>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Methoxphenidine is believed to be primarily an NMDA receptor antagonist, but its unique diarylethylamine structure makes its pharmacology distinct from classical dissociatives like ketamine or PCP. Limited research suggests it may have additional receptor interactions that contribute to its unpredictable and long-lasting effects.</p>
        
        <h4>Structural Classification</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>NMDA receptors</strong></span>
            <span class="affinity">Presumed antagonist activity</span>
            <span class="function">Primary dissociative effects, anesthesia</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Unknown targets</strong></span>
            <span class="affinity">Unclear interactions</span>
            <span class="function">Stimulating properties, unpredictable effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Diarylethylamine class</strong></span>
            <span class="affinity">Structural distinction</span>
            <span class="function">Different from arylcyclohexylamine dissociatives</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Unknown - limited pharmacokinetic data</p>
          <p><strong>Active metabolites:</strong> Possibly active metabolites contributing to long duration</p>
          <p><strong>Half-life:</strong> Estimated 8-16+ hours based on duration reports</p>
          <p><strong>Bioavailability:</strong> Unknown oral bioavailability</p>
          <p><strong>Peak plasma:</strong> Estimated 2-4 hours after oral dose</p>
          <p><strong>Duration:</strong> 6-12+ hours, significantly longer than most dissociatives</p>
        </div>

        <h4>Structural Uniqueness</h4>
        <div class="structural-info">
          <p><strong>Diarylethylamine backbone:</strong> Fundamentally different from ketamine/PCP family</p>
          <p><strong>Pyrrolidine ring:</strong> May contribute to unique pharmacological profile</p>
          <p><strong>Methoxy substitution:</strong> 2-methoxy group affects receptor binding and metabolism</p>
          <p><strong>Unknown pharmacology:</strong> Limited research on receptor binding profile</p>
        </div>

        <h4>Research Limitations</h4>
        <ul>
          <li><strong>Minimal studies:</strong> Very limited published research on pharmacology</li>
          <li><strong>Unknown safety profile:</strong> No formal toxicology studies</li>
          <li><strong>Unclear mechanism:</strong> Exact receptor targets unknown</li>
          <li><strong>Variable synthesis:</strong> Multiple synthesis routes may produce different impurities</li>
          <li><strong>No clinical data:</strong> Never studied in humans under controlled conditions</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†ÔøΩEÔøΩESafety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® EXTREME DANGER WARNINGS</h4>
          <ul>
            <li><strong>Unpredictable effects:</strong> Same dose can produce vastly different experiences</li>
            <li><strong>Extreme duration:</strong> 12+ hours of impairment with no antidote</li>
            <li><strong>Unknown long-term effects:</strong> No safety research whatsoever</li>
            <li><strong>Potential organ toxicity:</strong> Unknown toxicological profile</li>
            <li><strong>Caustic properties:</strong> Nasal administration causes severe tissue damage</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°ÔøΩEÔøΩEEssential Precautions</h4>
          <ul>
            <li>Never use alone - have sober, trusted sitter for entire duration</li>
            <li>Start with extremely low doses (25-50mg maximum)</li>
            <li>Wait minimum 4 hours before considering any redose</li>
            <li>Clear entire day/weekend - effects last 12+ hours</li>
            <li>Remove all hazards from environment</li>
            <li>Have emergency contacts readily available</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Never use if you have:</strong> Any mental health conditions, cardiovascular problems, liver/kidney disease, or are taking any medications. The unknown pharmacology and extreme duration make MXP particularly dangerous for vulnerable individuals.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏ÅEDrug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ EXTREMELY DANGEROUS</h4>
          <ul>
            <li><strong>All CNS depressants:</strong> Alcohol, benzodiazepines, opioids - respiratory depression</li>
            <li><strong>Other dissociatives:</strong> Unpredictable potentiation, dangerous duration extension</li>
            <li><strong>Stimulants:</strong> May interact unpredictably with MXP's stimulating properties</li>
            <li><strong>MAOIs:</strong> Unknown interactions with unclear pharmacology</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° UNKNOWN RISKS</h4>
          <ul>
            <li><strong>All medications:</strong> Unknown interactions due to unclear pharmacology</li>
            <li><strong>Psychedelics:</strong> Unpredictable psychological effects with long duration</li>
            <li><strong>Cannabis:</strong> May increase confusion and extend duration</li>
            <li><strong>Antidepressants:</strong> Unknown interactions</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† AVOID ALL COMBINATIONS</h4>
          <ul>
            <li><strong>General recommendation:</strong> Never combine MXP with any other substances</li>
            <li><strong>Unknown pharmacology:</strong> Impossible to predict interactions</li>
            <li><strong>Extreme duration:</strong> Any interaction lasts 12+ hours</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏ÅELegal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United States</h4>
            <p><strong>Unscheduled</strong> - Not federally controlled, but may fall under analogue laws. State laws vary significantly.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United Kingdom</h4>
            <p><strong>Class B</strong> - Controlled under Psychoactive Substances Act. Illegal to produce, supply, or possess.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE European Union</h4>
            <p><strong>Variable</strong> - Some countries have banned, others remain unscheduled. Check local laws.</p>
          </div>
          <div class="jurisdiction">
            <h4>üåç International</h4>
            <p><strong>Emerging controls</strong> - Increasingly being scheduled as countries identify risks.</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Research Status</h4>
          <p>No legitimate medical research or therapeutic applications for methoxphenidine. It exists purely as a research chemical with no established safety profile or medical utility.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö Research Chemical Development</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">~2013</span>
          <p>First synthesized as part of diarylethylamine dissociative research</p>
        </div>
        <div class="history-event">
          <span class="year">2014-2015</span>
          <p>Appears in research chemical vendor catalogs</p>
        </div>
        <div class="history-event">
          <span class="year">2015-2016</span>
          <p>Reports of unpredictable effects and extreme duration emerge</p>
        </div>
        <div class="history-event">
          <span class="year">2016</span>
          <p>UK Psychoactive Substances Act bans MXP</p>
        </div>
        <div class="history-event">
          <span class="year">2017+</span>
          <p>Declining availability as safety concerns mount</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Research Chemical Context</h4>
        <p>Methoxphenidine represents the risks of novel psychoactive substance development - a compound with unknown pharmacology, unpredictable effects, and no safety research being distributed to human users. Unlike other research chemicals that showed promise, MXP quickly developed a reputation for dangerous unpredictability.</p>
        
        <h4>Community Reception</h4>
        <p>The research chemical community generally regarded MXP with caution due to reports of extreme duration, unpredictable potency, and unique side effect profiles. Many experienced users avoided it after initial reports suggested it was fundamentally different and potentially more dangerous than established dissociatives.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Limited Research & Safety Concerns</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Pharmacological Studies</h4>
          <p>Virtually no published research on methoxphenidine's pharmacology, receptor binding, or mechanism of action. Most knowledge comes from user reports and chemical structural analysis.</p>
        </div>
        
        <div class="research-item">
          <h4>Toxicology Data</h4>
          <p>No formal toxicology studies. Safety profile unknown. Reports suggest potential for unusual adverse effects compared to other dissociatives.</p>
        </div>
        
        <div class="research-item">
          <h4>Case Reports</h4>
          <p>Limited case reports describe prolonged intoxication states, unpredictable dose responses, and difficult experiences lasting 12+ hours. Some reports of hospitalization.</p>
        </div>
        
        <div class="research-item">
          <h4>Structural Analysis</h4>
          <p>Chemical analysis confirms diarylethylamine structure distinct from arylcyclohexylamine dissociatives, potentially explaining unique pharmacological profile.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Resources & Support</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Emergency Services</h4>
        <ul>
          <li><strong>Medical Emergency:</strong> Call 911/emergency services immediately</li>
          <li><strong>Poison Control:</strong> 1-800-222-1222 (US)</li>
          <li><strong>Extended duration:</strong> Warn medical staff of 12+ hour duration</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Information Sources</h4>
        <ul>
          <li><a href="https://erowid.org/">Erowid</a> - Limited experience reports</li>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Research chemical data</li>
          <li><a href="https://bluelight.org/">Bluelight</a> - Community safety discussions</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Harm Reduction</h4>
        <ul>
          <li><a href="https://tripsit.me/">TripSit</a> - Crisis support chat</li>
          <li><a href="https://www.reddit.com/r/researchchemicals/">/r/researchchemicals</a> - Community warnings</li>
          <li><strong>General advice:</strong> Avoid this substance entirely</li>
        </ul>
      </div>
    </div>
  </div>

</div>


    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/Dyo-s-Dubious-Domain/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
</body>
</html>